Rupal Ojha

1.1k total citations
28 papers, 836 citations indexed

About

Rupal Ojha is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Rupal Ojha has authored 28 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Infectious Diseases. Recurrent topics in Rupal Ojha's work include vaccines and immunoinformatics approaches (17 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Rupal Ojha is often cited by papers focused on vaccines and immunoinformatics approaches (17 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Rupal Ojha collaborates with scholars based in India and United States. Rupal Ojha's co-authors include Vijay Kumar Prajapati, Rajan Kumar Pandey, Amit Mishra, Dhaneswar Prusty, Muthukalingan Krishnan, Nidhi Gupta, Satyendra Singh, Nazia Khatoon, Banoth Karan Kumar and Faheem Faheem and has published in prestigious journals such as Journal of the American Society of Nephrology, Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Rupal Ojha

27 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupal Ojha India 15 634 207 182 170 121 28 836
Sumeet Patiyal India 17 713 1.1× 109 0.5× 108 0.6× 135 0.8× 58 0.5× 50 896
Mohammad Reza Rahbar Iran 16 545 0.9× 107 0.5× 133 0.7× 148 0.9× 92 0.8× 44 776
Anjali Dhall India 16 588 0.9× 97 0.5× 98 0.5× 128 0.8× 60 0.5× 38 786
Elena Gustchina United States 15 317 0.5× 395 1.9× 140 0.8× 119 0.7× 63 0.5× 19 869
Israr Fatima China 8 325 0.5× 147 0.7× 89 0.5× 70 0.4× 70 0.6× 15 422
Ulf Schaefer United Kingdom 16 692 1.1× 121 0.6× 21 0.1× 235 1.4× 100 0.8× 23 1.3k
David Alderton United Kingdom 8 512 0.8× 221 1.1× 32 0.2× 107 0.6× 145 1.2× 8 918
Pratik Ghosh India 12 406 0.6× 358 1.7× 121 0.7× 137 0.8× 54 0.4× 18 652
Lilia M. Babé United States 16 418 0.7× 467 2.3× 119 0.7× 83 0.5× 132 1.1× 25 964
Victor C. Chu United States 12 366 0.6× 806 3.9× 68 0.4× 132 0.8× 250 2.1× 17 1.3k

Countries citing papers authored by Rupal Ojha

Since Specialization
Citations

This map shows the geographic impact of Rupal Ojha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupal Ojha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupal Ojha more than expected).

Fields of papers citing papers by Rupal Ojha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupal Ojha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupal Ojha. The network helps show where Rupal Ojha may publish in the future.

Co-authorship network of co-authors of Rupal Ojha

This figure shows the co-authorship network connecting the top 25 collaborators of Rupal Ojha. A scholar is included among the top collaborators of Rupal Ojha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupal Ojha. Rupal Ojha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ojha, Rupal, et al.. (2025). Neuroinflammation and Neurological Dysfunction After AKI Is Driven by Kidney-Released Osteopontin and Not Uremia. Journal of the American Society of Nephrology. 36(10S).
2.
3.
Ojha, Rupal, et al.. (2023). Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections. Biotechnology Letters. 45(7). 779–797. 7 indexed citations
4.
Ojha, Rupal, Kailash Chand, Balachandar Vellingiri, & Vijay Kumar Prajapati. (2023). Cloning, expression and in vitro validation of chimeric multi epitope vaccine candidate against visceral leishmaniasis infection. Life Sciences. 323. 121689–121689. 2 indexed citations
5.
Ojha, Rupal, et al.. (2022). Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2. Human Immunology. 83(4). 346–355. 9 indexed citations
6.
Pandey, Rajan Kumar, Rupal Ojha, Bajarang Vasant Kumbhar, et al.. (2022). Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection. Experimental Parasitology. 236-237. 108250–108250. 2 indexed citations
7.
Ojha, Rupal, et al.. (2022). Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria. Life Sciences. 311(Pt A). 121121–121121. 13 indexed citations
8.
Mattaparthi, Venkata Satish Kumar, Nidhi Gupta, Rupal Ojha, et al.. (2021). Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications. Journal of Biomolecular Structure and Dynamics. 40(19). 9543–9567. 20 indexed citations
9.
Pandey, Rajan Kumar, et al.. (2020). Immunoselective algorithm to devise multi-epitope subunit vaccine fighting against human cytomegalovirus infection. Infection Genetics and Evolution. 82. 104282–104282. 6 indexed citations
10.
Gupta, Nidhi, et al.. (2020). High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment. International Journal of Biological Macromolecules. 160. 1–17. 70 indexed citations
11.
Ojha, Rupal, Rajan Kumar Pandey, & Vijay Kumar Prajapati. (2020). Vaccinomics strategy to concoct a promising subunit vaccine for visceral leishmaniasis targeting sandfly and leishmania antigens. International Journal of Biological Macromolecules. 156. 548–557. 25 indexed citations
12.
Ojha, Rupal, Nidhi Gupta, Satyendra Singh, et al.. (2020). High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19. European Journal of Pharmaceutical Sciences. 151. 105375–105375. 42 indexed citations
13.
Ojha, Rupal, et al.. (2019). Strategic Development of a Next-Generation Multi-Epitope Vaccine To Prevent Nipah Virus Zoonotic Infection. ACS Omega. 4(8). 13069–13079. 58 indexed citations
14.
Pandey, Rajan Kumar, et al.. (2018). Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection. Vaccine. 36(17). 2262–2272. 113 indexed citations
15.
Pandey, Rajan Kumar, et al.. (2018). Chemical system biology based molecular interactions to identify inhibitors against Q151M mutant of HIV-1 reverse transcriptase. Infection Genetics and Evolution. 63. 5–12. 5 indexed citations
16.
Ojha, Rupal, et al.. (2018). Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing immunoinformatic approaches. International Journal of Biological Macromolecules. 118(Pt A). 180–188. 36 indexed citations
17.
18.
Ojha, Rupal, et al.. (2018). Emerging Role of Circular RNAs as Potential Biomarkers for the Diagnosis of Human Diseases. Advances in experimental medicine and biology. 1087. 141–157. 64 indexed citations
19.
Ojha, Rupal, Nazia Khatoon, & Vijay Kumar Prajapati. (2018). Conglomeration of novel Culex quinquefasciatus salivary proteins to contrive multi-epitope subunit vaccine against infections caused by blood imbibing transmitter. International Journal of Biological Macromolecules. 118(Pt A). 834–843. 13 indexed citations
20.
Khatoon, Nazia, Rupal Ojha, Amit Mishra, & Vijay Kumar Prajapati. (2018). Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism. Vaccine. 36(42). 6290–6300. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumeet Patiyal Breakdown of academic impact, for papers by Mohammad Reza Rahbar Breakdown of academic impact, for papers by Anjali Dhall Breakdown of academic impact, for papers by Elena Gustchina Breakdown of academic impact, for papers by Israr Fatima Breakdown of academic impact, for papers by Ulf Schaefer Breakdown of academic impact, for papers by David Alderton Breakdown of academic impact, for papers by Pratik Ghosh Breakdown of academic impact, for papers by Lilia M. Babé Breakdown of academic impact, for papers by Victor C. Chu
Rankless by CCL
2026